GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eurobio Scientific (XPAR:ALERS) » Definitions » EV-to-EBITDA

Eurobio Scientific (XPAR:ALERS) EV-to-EBITDA : 6.25 (As of May. 16, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Eurobio Scientific EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Eurobio Scientific's enterprise value is €159.9 Mil. Eurobio Scientific's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €25.6 Mil. Therefore, Eurobio Scientific's EV-to-EBITDA for today is 6.25.

The historical rank and industry rank for Eurobio Scientific's EV-to-EBITDA or its related term are showing as below:

XPAR:ALERS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -22.22   Med: -2.54   Max: 28.68
Current: 6.25

During the past 13 years, the highest EV-to-EBITDA of Eurobio Scientific was 28.68. The lowest was -22.22. And the median was -2.54.

XPAR:ALERS's EV-to-EBITDA is ranked better than
83.61% of 488 companies
in the Medical Devices & Instruments industry
Industry Median: 16.1 vs XPAR:ALERS: 6.25

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-16), Eurobio Scientific's stock price is €14.70. Eurobio Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.478. Therefore, Eurobio Scientific's PE Ratio for today is 30.75.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Eurobio Scientific EV-to-EBITDA Historical Data

The historical data trend for Eurobio Scientific's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurobio Scientific EV-to-EBITDA Chart

Eurobio Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.78 1.77 2.79 5.89 6.94

Eurobio Scientific Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.79 - 5.89 - 6.94

Competitive Comparison of Eurobio Scientific's EV-to-EBITDA

For the Medical Devices subindustry, Eurobio Scientific's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurobio Scientific's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Eurobio Scientific's EV-to-EBITDA falls into.



Eurobio Scientific EV-to-EBITDA Calculation

Eurobio Scientific's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=159.942/25.583
=6.25

Eurobio Scientific's current Enterprise Value is €159.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurobio Scientific's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €25.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eurobio Scientific  (XPAR:ALERS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Eurobio Scientific's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=14.70/0.478
=30.75

Eurobio Scientific's share price for today is €14.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Eurobio Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.478.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Eurobio Scientific EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Eurobio Scientific's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurobio Scientific (XPAR:ALERS) Business Description

Traded in Other Exchanges
Address
63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.

Eurobio Scientific (XPAR:ALERS) Headlines

No Headlines